CLINICAL IMMUNOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2023-09-12 ms3000001172067463 来自重庆

焦灼啊！！！投稿2个月还找不到审稿人

37 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2023-12-11 Jacinth 来自广东省

偏重的研究方向：肿瘤免疫
经验分享：请问一下这个杂志with editor多久后有结果

30 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2024-02-27 5.14 来自广西

投稿时section/category选不了怎么办

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2021-10-28 1581f9a412m

即时IF已经过5分了，看来明年看涨，大家可以及时关注。

82 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2022-05-30 钮祜禄

偏重的研究方向：肿瘤免疫
经验分享：请问这个杂志接收case report么？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2011-10-29 also1133

审稿速度:1.0 | 投稿命中率:25.0
经验分享：好快的速度，24小时就被主编拒了。

539 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2020-10-25 fanxk

审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0
偏重的研究方向：肿瘤免疫
经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。

161 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2021-07-06 14853f13m21(暂无昵称)

审稿速度:12.0 | 投稿命中率:95.0
偏重的研究方向：免疫学;肿瘤学
经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！

86 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2020-03-23 有梦想的男生

审稿速度:2.0 | 投稿命中率:25.0
经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！

175 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157287, encodeId=d009215e287c3, content=焦灼啊！！！投稿2个月还找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00d16160033, createdName=ms3000001172067463, createdTime=Tue Sep 12 11:32:34 CST 2023, time=2023-09-12, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2174323, encodeId=4c2f21e4323e6, content=偏重的研究方向：肿瘤免疫 经验分享：请问一下这个杂志with editor多久后有结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230305/6dde92a22fc046ce97bac5aa409b06eb/2b385598b8c1466f9d564e5a3679cd61.jpg, createdBy=c9cf2486248, createdName=Jacinth, createdTime=Mon Dec 11 20:50:02 CST 2023, time=2023-12-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2189552, encodeId=992e2189552b6, content=投稿时section/category选不了怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=415a5446255, createdName=5.14, createdTime=Tue Feb 27 01:22:16 CST 2024, time=2024-02-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1064703, encodeId=bb231064e0392, content=即时IF已经过5分了，看来明年看涨，大家可以及时关注。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=724a2115896, createdName=1581f9a412m, createdTime=Thu Oct 28 16:10:32 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223459, encodeId=6538122345931, content=偏重的研究方向：肿瘤免疫 经验分享：请问这个杂志接收case report么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211004/299253452aeb48dc9e0f8987e1a1cfe3/53348402bc724865bd8321a5f9b46bdb.jpg, createdBy=01db5551318, createdName=钮祜禄, createdTime=Mon May 30 22:21:36 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=485095, encodeId=9757485095dc, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：好快的速度，24小时就被主编拒了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8cca18508, createdName=also1133, createdTime=Sat Oct 29 17:32:00 CST 2011, time=2011-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894320, encodeId=4ab5894320ab, content=审稿速度:3.0 | 投稿命中率:25.0 | 版面费用:3610.0 偏重的研究方向：肿瘤免疫 经验分享：综述一篇，4月8日投稿，7月7日修回，7月28日接受，7月31日online，感觉挺快的，出乎我意料。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ffb2838070, createdName=fanxk, createdTime=Sun Oct 25 15:09:06 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996900, encodeId=5aa09969000d, content=审稿速度:12.0 | 投稿命中率:95.0 偏重的研究方向：免疫学;肿瘤学 经验分享：1月30日投的，3月30日还在with editor,发邮件催之后第二天变under review了，然后under review的状态维持了3个月，7月6日外审一点意见都没回来。官僚速度，写邮件去骂了它们一顿，并要求撤稿。渣男杂志，毁我青春！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54995286478, createdName=14853f13m21(暂无昵称), createdTime=Tue Jul 06 20:55:29 CST 2021, time=2021-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587244, encodeId=93e458e2442b, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿修回了2次，总的来说还可以，只是时间比较长！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/15/f239eef6ba118e7cc19acd1e697033b1.jpg, createdBy=1be35197496, createdName=有梦想的男生, createdTime=Mon Mar 23 00:00:00 CST 2020, time=2020-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204591, encodeId=8c35120459182, content=这个杂志要原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Mon Mar 21 12:37:02 CST 2022, time=2022-03-21, status=1, ipAttribution=)]

2022-03-21 12133f96m16(暂无昵称)

这个杂志要原始数据吗

60 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务